Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ETC With or Without DAC N-055 in Cutaneous Leishmaniasis
NCT00947362Phase 3Completed
- Sponsor
- Waisenmedizin e.V.
- Start
- Aug 2004
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sodium chlorosum in cutaneous leishmaniasis (CL), sponsored by Waisenmedizin e.V.. Started Aug 2004; status: completed.
02
Drugs
sodium chlorosum
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on NCT00947362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00947362.